With over 30 years of experience in the healthcare industry, Jane Griffiths is currently the Global Head of Actelion, a Swiss company acquired by Johnson & Johnson in June 2017.

Prior to stepping into her role at Actelion in June 2017, Jane was Company Group Chairman at Janssen EMEA (the pharmaceutical division of Johnson & Johnson) for over six years, responsible for the entire business across the region. Jane’s personal business approach is to focus on openness, collaboration, sustainability, and accountability. She also believes strongly in improving the reputation of the pharmaceutical industry. Through her roles as Chair of the Johnson & Johnson Corporate Citizenship Trust in EMEA and Sponsor of the Janssen Global Pharmaceuticals Sustainability Council, she and her colleagues are working together to implement these values.

Jane is a passionate advocate for women in business and STEM education. Jane was the first female Company Group Chairman of Janssen EMEA and is passionate about encouraging more female talent to pursue leadership roles. She is a Sponsor of the Johnson & Johnson Women’s Leadership Initiative.

Since completing her PhD in Plant Biochemistry at the University College of Wales, Aberystwyth, UK, in 1985, Jane has held various roles within Johnson & Johnson, starting as a sales representative. She has gained in-depth knowledge of oncology, haematology and psychiatry, and significant experience in HIV and HCV. Her previous roles include international and affiliate marketing, sales management, sales, product management, and clinical research.